Monokines

DBCAT003914Pharmacologic class

Soluble mediators of the immune response that are neither antibodies nor complement. They are produced largely, but not exclusively, by monocytes and macrophages. A DrugBank category of 3 drugs.

Drugs: Interleukin-1 alpha, human recombinant
Tengonermin
XPro1595

What you can answer from here — as of June 18, 2018

3DrugsEach linked to its full drug card

Listed above

3Drug targetsEvery drug–target pair in the class, with bond type

1Marketed productAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Monokines share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account